Abstract
Background and importanceR&D and market entry for orphan medicinal products (OMPs) are incentivised with a 10-year market exclusivity period as stated in Regulation (EC) No 141/2000. Notably, OMP prices often...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have